-+ 0.00%
-+ 0.00%
-+ 0.00%
According to the Huaxi Securities Research Report, Yao Ming Kangde's performance significantly exceeded market expectations, revised its 26-year revenue guidelines, and maintained core recommendations. 26H1 achieved operating income of 28.897 billion yuan, a year-on-year increase of 38.93%, and realized net profit to mother of 11.080 billion yuan, an increase of 29.43% over the previous year. As of the end of June '26, the company's ongoing business orders were 59.77 billion yuan, an increase of 23.6% over the previous year, showing rapid growth and laying the foundation for future performance growth. According to the company's 2026 interim report, the company revised its 26-year performance guidelines, that is, revenue was raised from 513-53 billion yuan to 585-60.5 billion yuan, the year-on-year growth rate of revenue from continuing operations was raised from 18% to 22% to 35% to 39%, and the adjusted net interest rate remained relatively stable in 2026. Benefiting from pipeline molecular growth and the release of superimposed production capacity, the company's D&M business 26H1 achieved revenue of 14.99 billion yuan, an increase of 72.7% over the previous year, continuing the rapid growth trend. Maintain a “buy” rating.
Share
Listen to the news
According to the Huaxi Securities Research Report, Yao Ming Kangde's performance significantly exceeded market expectations, revised its 26-year revenue guidelines, and maintained core recommendations. 26H1 achieved operating income of 28.897 billion yuan, a year-on-year increase of 38.93%, and realized net profit to mother of 11.080 billion yuan, an increase of 29.43% over the previous year. As of the end of June '26, the company's ongoing business orders were 59.77 billion yuan, an increase of 23.6% over the previous year, showing rapid growth and laying the foundation for future performance growth. According to the company's 2026 interim report, the company revised its 26-year performance guidelines, that is, revenue was raised from 513-53 billion yuan to 585-60.5 billion yuan, the year-on-year growth rate of revenue from continuing operations was raised from 18% to 22% to 35% to 39%, and the adjusted net interest rate remained relatively stable in 2026. Benefiting from pipeline molecular growth and the release of superimposed production capacity, the company's D&M business 26H1 achieved revenue of 14.99 billion yuan, an increase of 72.7% over the previous year, continuing the rapid growth trend. Maintain a “buy” rating.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending